Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Non-Current Debt (2021)

Whitehawk Therapeutics (WHWK) has disclosed Non-Current Debt for 1 consecutive years, with $5.8 million as the latest value for Q4 2021.

  • Quarterly Non-Current Debt changed N/A to $5.8 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Dec 2021, changed N/A year-over-year, with the annual reading at $5.8 million for FY2021, N/A changed from the prior year.
  • Non-Current Debt for Q4 2021 was $5.8 million at Whitehawk Therapeutics, roughly flat from $5.8 million in the prior quarter.
  • The five-year high for Non-Current Debt was $5.8 million in Q3 2021, with the low at $5.8 million in Q3 2021.